Radiation therapy for post-operative recurrence: yes, but only for limited indications

Subotic, Dragan, Van Schil, Paul, Grigoriu, Bogdan

Source: Eur Respir J 2016; 48: 278-279

Journal Issue: July

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Subotic, Dragan, Van Schil, Paul, Grigoriu, Bogdan. Radiation therapy for post-operative recurrence: yes, but only for limited indications. Eur Respir J 2016; 48: 278-279

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too! Source: Eur Respir J 2016; 48: 276-278 Year: 2016
Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis Source: Annual Congress 2007 - Controversies in surgical oncology Year: 2007
Surgery for mesothelioma: is curative surgery the past or the future? Source: International Congress 2014 – Mesothelioma: a never-ending story Year: 2014
Can we still justify pneumonectomy following induction chemotherapy? Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT). Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Physiotherapy intervention is safety in early postoperative patients after cardiac surgery? Source: International Congress 2017 – Airway clearance techniques and respiratory physiotherapy in hospitalized patients Year: 2017
Stage I NSCLC: the extent of surgical resection needed, or, better yet, radiotherapy? Source: International Congress 2017 – Rational strategies for specific treatment situations in lung cancer Year: 2017
Improved overall survival after late recurrence of lung cancer following the introduction of CT-based follow-up for patients treated with curative intent Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies Year: 2018
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020
Functional selection criteria before definitive radiotherapy and chemotherapy Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients Year: 2009
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Source: Eur Respir J 2007; 29: 117-126 Year: 2007